Showing results (281-290 of 412) with videos related to

Sort By:
Pageof 42
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Acute effect of pegvisomant on cardiovascular risk markers in healthy men: implications for the pathogenesis of atherosclerosis in GH deficiencyA F Muller, F W Leebeek, J A Janssen, et al.
Diabetes Care|May 1, 1997
Insulin and cognitive function in an elderly population. The Rotterdam StudyR P Stolk, M M Breteler, A Ott, et al.
Clinical Endocrinology|June 26, 1998
Serum free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levelsJ A Janssen, R P Stolk, H A Pols, et al.
The Journal of Clinical Endocrinology and Metabolism|September 1, 1993
A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomasF R Nobels, D J Kwekkeboom, W Coopmans, et al.
Acta Neurochirurgica|January 1, 1986
Influence of transsphenoidal hypophysectomy on visual deficit due to a pituitary tumourG Blaauw, R Braakman, M Cuhadar, et al.
Brain Research|July 1, 1987
Hydrocortisone stimulates the development of oligodendrocytes in primary glial cultures and affects glucose metabolism and lipid synthesis in these culturesR A Warringa, R C Hoeben, J W Koper, et al.
Leukemia|May 23, 2001
Somatostatin induces migration of acute myeloid leukemia cells via activation of somatostatin receptor subtype 2S P Oomen, E G Lichtenauer-Kaligis, N Verplanke, et al.
The Netherlands Journal of Medicine|September 1, 1996
An unusual case of multiple endocrine neoplasia type 1 and the role of 111In-pentetreotide scintigraphyH H Ponssen, W W de Herder, H J Bonjer, et al.
Frontiers in Neuroendocrinology|January 1, 1993
Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphyS W Lamberts, L J Hofland, W W de Herder, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1991
Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian diseaseB C Fauser, T D Pache, S W Lamberts, et al.
Pageof 42